Table 3.

Biological parameters.

	Global Cohort	AKI SCyC	No AKI SCyC	p-Value
	n = 100	n = 10	n = 90
Serum Creatinine level—µmol/L
Baseline	113.6 ± 77.9	135.9 ± 89.9	111.2 ± 76.6	0.34
Post TAVR—H0	103.2 ± 98.8	141.7 ± 150.5	98.8 ± 91.4	0.2
Post TAVR—Day 1	108.6 ± 115.7	172.6 ± 193.5	101.5 ± 103	0.065
Post TAVR—Day 3	108.5 ± 95.5	177.1 ± 174.4	100.9 ± 80.4	0.016
Serum Cystatin—mg/L
Baseline	1.7 ± 0.9	1.9 ± 1	1.7 ± 0.9	0.59
Post TAVR—Day 1	1.6 ± 1	2.2 ± 1.6	1.5 ± 0.8	0.025
Post TAVR—Day 3	1.6 ± 1	2.3 ± 1.7	1.6 ± 0.8	0.029
Haemoglobin—g/dL
Baseline	12 (11–13.1)	10.2 (9.3–10.9)	11.2 (10.2–12.2)	0.17
Post TAVR—Day 1	10.2 (9.6–10.7)	10.2 (9.6–10.7)	10.6 (9.5–11.6)	0.25
Post TAVR—Day 3	9.6 (8.5–9.95)	9.6 (8.5–9.9)	10 (9.2–11)	0.08
BNP—ng/L ± SD
Baseline	471 ± 856	561 ± 848	461 ± 862	0.73
Post TAVR—H0	515 ± 920	690 ± 1140	495 ± 898	0.53
Post TAVR—Day 1	426 ± 747	686 ± 1185	397 ± 684	0.24
Post TAVR—Day 3	283 ± 402	511 ± 674	257 ± 356	0.058
Post TAVR—Day 3	60.8 ± 47	66.2 ± 86.7	60.2 ± 41	0.7

Data are presented as mean ± or n (%) or median (25th–75th percentile). AKI = Acute Kidney Injury; TAVR = Transcatheter aortic valve replacement.